| Autor: |
Fedotova EY; Research Center of Neurology, 125367 Moscow, Russia., Iakovenko EV; Research Center of Neurology, 125367 Moscow, Russia., Abramycheva NY; Research Center of Neurology, 125367 Moscow, Russia., Illarioshkin SN; Research Center of Neurology, 125367 Moscow, Russia. |
| Jazyk: |
angličtina |
| Zdroj: |
Epigenomes [Epigenomes] 2023 Feb 06; Vol. 7 (1). Date of Electronic Publication: 2023 Feb 06. |
| DOI: |
10.3390/epigenomes7010005 |
| Abstrakt: |
In recent years, epigenetic mechanisms have been implicated in the development of multifactorial diseases including neurodegenerative disorders. In Parkinson's disease (PD), as a synucleinopathy, most studies focused on DNA methylation of SNCA gene coding alpha-synuclein but obtained results were rather contradictory. In another neurodegenerative synucleinopathy, multiple system atrophy (MSA), very few studies investigated the epigenetic regulation. This study included patients with PD (n = 82), patients with MSA (n = 24), and a control group (n = 50). In three groups, methylation levels of CpG and non-CpG sites in regulatory regions of the SNCA gene were analyzed. We revealed hypomethylation of CpG sites in the SNCA intron 1 in PD and hypermethylation of predominantly non-CpG sites in the SNCA promoter region in MSA. In PD patients, hypomethylation in the intron 1 was associated with earlier age at the disease onset. In MSA patients, hypermethylation in the promotor was associated with shorter disease duration (before examination). These results showed different patterns of the epigenetic regulation in two synucleinopathies-PD and MSA. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
